[1] |
Laskar S, Muckaden MA, Bahl G, et al. Primary non-Hodgkin's lymphoma of the nasopharynx:prognostic factors and outcome of 113 Indian patients[J]. Leuk Lymphoma, 2006, 47(10):2132-2139.DOI:10.1080/10428190600733531. |
[2] |
Ezzat AA, Ibrahim EM, El Weshi AN, et al. Localized non-Hodgkin's lymphoma of Waldeyer's ring:clinical features, management, and prognosis of 130 adult patients[J]. Head Neck, 2001, 23(7):547-558. DOI:10.1002/hed.1077. |
[3] |
党娜, 徐文贵, 宋秀宇, 等. 18F-FDG PET-CT显像在原发结外淋巴瘤诊断中的应用价值[J].中华血液学杂志, 2014, 35(1):35-39. DOI:10.3760/cma.j.issn.0253-2727.2014.01.009. Dang N, Xu WG, Song XY, et al. The diagnostic value of 18F-FDG PET-CT imaging in patients with primary extranodal lymphoma[J]. Chin J Hematol, 2014, 35(1):35-39. doi: 10.3760/cma.j.issn.0253-2727.2014.01.009 |
[4] |
程玮, 常乃柏, 李江涛, 等. 18F-脱氧葡萄糖正电子发射计算机断层显像对淋巴瘤分期和预后评价的作用[J].白血病·淋巴瘤, 2012, 21(5):277-281. DOI:10.3760/cma.j.issn.1009-9921. 2012. 05.006. Cheng W, Chang NB, Li JT, et al. Role of 18fluoro-deoxyglucose positron emission tomography on staging and predicting outcome in patients with lymphoma[J]. J Leukemia Lymphoma, 2012, 21(5):277-281. doi: 10.3760/cma.j.issn.1009-9921.2012.05.006 |
[5] |
张雯杰, 郑容, 吴宁. 18F-氟代脱氧葡萄糖PET在鼻咽癌中的临床应用价值[J].国际放射医学核医学杂志, 2006, 30(2):94-97. DOI:10.3760/cma.j.issn.1673-4114.2006.02.009. Zhang WJ, Zheng R, Wu N. Application of 18F-fluorodeoxyglucose PET in nasopharyngeal carcinoma[J]. Int J Radiat Med Nucl Med, 2006, 30(2):94-97. doi: 10.3760/cma.j.issn.1673-4114.2006.02.009 |
[6] |
冯彦林, 王颖, 张宁, 等.鼻咽癌不同模式放疗后的PET/CT早期评估价值的研究[J].国际放射医学核医学杂志, 2014, 38(4):223-226, 246. DOI:10.3760/cma.j.issn.1673-4114.2014.04.004. Feng YL, Wang Y, Zhang N, et al. Early evaluation value of PET/CT in nasopharyngeal carcinoma after different models of radiother-apy[J]. Int J Radiat Med Nucl Med, 2014, 38(4):223-226, 246. doi: 10.3760/cma.j.issn.1673-4114.2014.04.004 |
[7] |
田月丽, 兰晓莉, 张永学. 18F-FDG PET/CT在鼻咽癌综合治疗后患者随访及预后评估中的价值[J].国际放射医学核医学杂志, 2013, 37(6):359-363, 377. DOI:10.3760/cma.j.issn.1673-4114. 2013. 06.009. Tian YL, Lan XL, Zhang YX. Prognostic value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients follow-up after comprehen-sive therapy[J]. Int J Radiat Med Nucl Med, 2013, 37(6):359-363, 377. doi: 10.3760/cma.j.issn.1673-4114.2013.06.009 |
[8] |
King AD, Lei KI, Richards PS, et al. Non-Hodgkin's lymphoma of the nasopharynx:CT and MR imaging[J]. Clin Radiol, 2003, 58(8):621-625. DOI:101016/S0009-9260(03)00182-X. |
[9] |
Cho KS, Kang DW, Kim HJ, et al. Differential diagnosis of primary nasopharyngeal lymphoma and nasopharyngeal carcinoma focusing on CT, MRI, and PET/CT[J]. Otolaryngol Head Neck Surg, 2012, 146(4):574-578. DOI:10.1177/0194599811434712. |
[10] |
李晓清, 杨天和, 林建忠, 等, 鼻咽部淋巴瘤的MRI表现[J].磁共振成像, 2015, 6(5):349-353. DOI:10.3969/j.issn.1674-8034. 2015. 05.006. Li XQ, Yang TH, Lin JZ, et al. Nasopharyngeal lymphoma on MRI[J]. Chin J Magn Reson Imaging, 2015, 6(5):349-353. doi: 10.3969/j.issn.1674-8034.2015.05.006 |
[11] |
King AD, Bhatia KS. Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck[J]. World J Radiol, 2010, 2(5):159-165. DOI:10.4329/wjr.v2.i5.159. |
[12] |
King AD, Lam WW, Leung SF, et al. MRI of local disease in nasopharyngeal carcinoma:tumour extent vs tumour stage[J]. Br J Radiol, 1999, 72(826):734-741. DOI:10.1259/bjr.72.860. 10624338. |
[13] |
Zhang SX, Han PH, Zhang GQ, et al. Comparison of SPECT/CT, MRI and CT in diagnosis of skull base bone invasion in nasopha-ryngeal carcinoma[J]. Biomed Mater Eng, 2014, 24(1):1117-1124.DOI:10.3233/BME-130911. |
[14] |
张嵘, 谢传淼, 莫运仙, 等.鼻咽非霍奇金淋巴瘤的MRI表现与侵犯特点[J].中华放射学杂志, 2011, 45(2):170-173. DOI:10.3760/cma.j.issn.1005-1201.2011.02.017. Zhang R, Xie CM, Mo YX, et al. Non-Hodgkin lymphoma at nasopharynx:features of MRI[J]. Chin J Radiol, 2011, 45(2):170-173. doi: 10.3760/cma.j.issn.1005-1201.2011.02.017 |
[15] |
张建华, 王荣福, 范岩, 等. 18F-FDG PET/CT评价初诊非霍奇金淋巴瘤代谢活性及其与免疫表型的相关性[J].中华医学杂志, 2014, 94(33):2576-2579. DOI:10.3760/cma.j.issn.0376-2491. 2014. 33.006. Zhang JH, Wang RF, Fan Y, et al. Metabolic activity measured by 18F-FDG PET/CT in newly diagnosed patients with non-Hodgkin lymphoma:correlation with immunophenotyped[J]. Natl Med J China, 2014, 94(33):2576-2579. doi: 10.3760/cma.j.issn.0376-2491.2014.33.006 |
[16] |
Hanna E, Wanamaker J, Adelstein D, et al. Extranodal lymphomas of the head and neck. A 20-year experience[J/OL]. Arch Otolaryngol Head Neck Surg, 1997, 123(12):1318-1323. DOI:10.1001/archotol.1997.01900120068011. |
[17] |
罗德红, 周纯武, 姚雪松, 等.鼻咽癌颈部淋巴结转移的CT表现[J].临床放射学杂志, 2007, 26(12):1199-1203. DOI:10.3969/j.issn.1001-9324. 2007.12.008. Luo DH, Zhou CW, Yao XS, et al. The CT Manifestations of the Cervical Lymphnode Metastasis of the Nasopharyngeal Carcinoma[J]. J Clin Radiol, 2007, 26(12):1199-1203. doi: 10.3969/j.issn.1001-9324.2007.12.008 |
[18] |
李静, 石木兰, 王爽.恶性淋巴瘤和头颈部鳞癌颈部受累淋巴结的CT与病理比较[J].中华放射学杂志, 2002, 36(8):737-740. DOI:10.3760/J.ISSN:1005=1201.2002.08.016. Li J, Shi ML, Wang S. CT manifestations of cervical lymph node pathology:lymphoma vs metastatic squamous cell carcinoma[J]. Chin J Radiol, 2002, 36(8):737-740. doi: 10.3760/J.ISSN:1005=1201.2002.08.016 |